Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2′-deoxycytidine treatment

被引:51
作者
Egger, Gerda
Aparicio, Ana M.
Escobar, Sonia G.
Jones, Peter A.
机构
[1] Univ So Calif, Keck Sch Med, Dept Urol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA
[2] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA
关键词
D O I
10.1158/0008-5472.CAN-06-2845
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic drugs are in use in clinical trials of various human cancers and are potent at reactivating genes silenced by DNA methylation and chromatin modifications. We report here the analysis of a set of normal fibroblast and cancer cell lines after combination treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-CdR) and the historic deacetylase inhibitor 4-phenylbutyric acid (PBA). Low doses of the drug combination caused cell cycle arrest, whereas high doses induced apoptosis in T24 bladder carcinoma cells. Both p16 (CDKN2A/INK4) and p21 (CIP1/SDII/WAF1) expression were induced to similar levels in normal and cancer cells in a dose-dependent fashion after combination treatments. We detected a distinct increase of histone H3 acetylation at lysine 9/14 near the transcription start sites, in both LD419 normal fibroblasts and T24 bladder carcinoma cells, whereas the acetylation changes in the p21 locus were less apparent. Interestingly, the levels of trimethylation of histone H3 on lysine 9, which usually marks inactive chromatin regions and was associated with the p16 promoter in silenced T24 cells, did not change after drug treatments. Furthermore, we provide evidence that the remethylation of the p16 promoter CpG island in T24 cells after 5-aza-CdR treatment cannot be halted by subsequent continuous PBA treatment. The p16 gene is resilenced with kinetics similar to 5-aza-CdR only-treated cells, which is also marked by a localized loss of histone acetylation at the transcription start site. Altogether, our data provide new insights into the mechanism of epigenetic drugs and have important implications for epigenetic therapy.
引用
收藏
页码:346 / 353
页数:8
相关论文
共 44 条
[1]   The p21WAF1/CIP1 promoter is methylated in rat-1 cells:: Stable restoration of p53-dependent p21WAF1/CIP1 expression after transfection of a genomic clone containing the p21WAF1/CIP1 gene [J].
Allan, LA ;
Duhig, T ;
Read, M ;
Fried, M .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) :1291-1298
[2]  
Belinsky SA, 2003, CANCER RES, V63, P7089
[3]  
Bender CM, 1998, CANCER RES, V58, P95
[4]   Antineoplastic action of 5-aza-2′-deoxycytidine and phenylbutyrate on human lung carcinoma cells [J].
Boivin, AJ ;
Momparler, LF ;
Hurtubise, A ;
Momparler, RL .
ANTI-CANCER DRUGS, 2002, 13 (08) :869-874
[5]   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].
Cameron, EE ;
Bachman, KE ;
Myöhänen, S ;
Herman, JG ;
Baylin, SB .
NATURE GENETICS, 1999, 21 (01) :103-107
[6]  
Chen B, 2000, CANCER RES, V60, P3290
[7]   Molecular cloning and tissue-specific, developmental-stage-specific, and hormonal regulation of IGFBP3 gene in zebrafish [J].
Chen, JY ;
Chen, JC ;
Huang, WT ;
Liu, CW ;
Hui, CF ;
Chen, TT ;
Wu, JL .
MARINE BIOTECHNOLOGY, 2004, 6 (01) :1-7
[8]   Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells [J].
Cheng, JC ;
Weisenberger, DJ ;
Gonzales, FA ;
Liang, GN ;
Xu, GL ;
Hu, YG ;
Marquez, VE ;
Jones, PA .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :1270-1278
[9]   Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene [J].
Chiurazzi, P ;
Pomponi, MG ;
Pietrobono, R ;
Bakker, CE ;
Neri, G ;
Oostra, BA .
HUMAN MOLECULAR GENETICS, 1999, 8 (12) :2317-2323
[10]   Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects [J].
Cimini, D ;
Mattiuzzo, M ;
Torosantucci, L ;
Degrassi, F .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (09) :3821-3833